| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.08 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |